Skip to main content
. 2022 Nov 11;10(11):1908. doi: 10.3390/vaccines10111908

Figure 1.

Figure 1

Excess (a) acute and (b) ICU beds used for treatment of COVID-19 and influenza patients by vaccine coverage (base case scenario: QIVe for all age groups) and (c) acute and (d) ICU beds used for treatment of COVID-19 and influenza patients by vaccine coverage (scenario 2: QIVc for 6 months to 64 years, aQIV for ≥65 years) during high and low incidence influenza seasons.